AI assistant
Sending…
ANI PHARMACEUTICALS INC — Director's Dealing 2026
Feb 17, 2026
31676_dirs_2026-02-17_2ab3dde0-4ee3-404f-9599-048941e95cbb.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ANI PHARMACEUTICALS INC (ANIP)
CIK: 0001023024
Period of Report: 2026-02-12
Reporting Person: Davis Krista (SVP, CHIEF HR OFFICER)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2026-02-12 | Common Stock | F | 1180 | $76.70 | Disposed | 54367 | Direct |
| 2026-02-14 | Common Stock | F | 1290 | $77.36 | Disposed | 53077 | Direct |
Footnotes
F1: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,264 shares of restricted stock, the grant of which was previously reported on February 18, 2025.
F2: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,020 shares of restricted stock, the grant of which was previously reported on February 16, 2024.
More from ANI PHARMACEUTICALS INC
Declaration of Voting Results & Voting Rights Announcements
2026
May 21
Report Publication Announcement
2026
May 13
Interim / Quarterly Report
2026
May 8
Report Publication Announcement
2026
May 8
Annual Report
2026
Apr 9
Proxy Solicitation & Information Statement
2026
Apr 9
Regulatory Filings
2026
Apr 7
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 4
Investor Presentation
2026
Mar 3